Trump reach­es for his pen as long-await­ed ex­ec­u­tive or­der on drug man­u­fac­tur­ing on-shoring fi­nal­ly ar­rives — re­ports

Pres­i­dent Trump will sign a long-ru­mored ex­ec­u­tive or­der lat­er to­day that is de­signed to spur more made-in-the-USA ther­a­pies, ac­cord­ing to a slate of new re­ports out Thurs­day morn­ing.

Drug man­u­fac­tur­ing cir­cles have been buzzing about this EO for months now, won­der­ing how Trump plans to re­quire the on-shoring of cer­tain ther­a­pies.

Ac­cord­ing to the Bloomberg re­port, White House trade ad­vis­er Pe­ter Navar­ro told re­porters that the ad­min­is­tra­tion will come up with a list of es­sen­tial med­i­cines Trump wants to have made in­side the US. The or­der will di­rect gov­ern­ment pur­chasers to buy these es­sen­tial meds from US sup­pli­ers. The re­ports add that the or­der re­lax­es drug safe­ty and en­vi­ron­men­tal reg­u­la­tions to make it hap­pen.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER